Linden Advisors’s Tevogen Inc. Warrant TVGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.5K Hold
649,999
﹤0.01% 538
2025
Q4
$25K Hold
649,999
﹤0.01% 447
2025
Q3
$34.8K Hold
649,999
﹤0.01% 381
2025
Q2
$42.3K Hold
649,999
﹤0.01% 343
2025
Q1
$32.2K Hold
649,999
﹤0.01% 274
2024
Q4
$39.6K Hold
649,999
﹤0.01% 223
2024
Q3
$7.87K Hold
649,999
﹤0.01% 255
2024
Q2
$13.1K Hold
649,999
﹤0.01% 251
2024
Q1
$51.7K Hold
649,999
﹤0.01% 229
2023
Q4
$22.8K Hold
649,999
﹤0.01% 251
2023
Q3
$31.3K Hold
649,999
﹤0.01% 281
2023
Q2
$27K Hold
649,999
﹤0.01% 302
2023
Q1
$55.3K Hold
649,999
﹤0.01% 315
2022
Q4
$4.22K Hold
649,999
﹤0.01% 544
2022
Q3
$75K Hold
649,999
﹤0.01% 494
2022
Q2
$101K Hold
649,999
﹤0.01% 523
2022
Q1
$179K Buy
+649,999
New +$242K ﹤0.01% 545

Other funds holding TVGNW

Linden Advisors's TVGNW Position: Q1 2026 in Review

Linden Advisors held its Tevogen Inc. Warrant (TVGNW) position steady in Q1 2026 at 649,999 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #538.

Linden Advisors first reported a position in TVGNW in Q1 2022 and has held it in 17 quarters since. The position peaked at $179K in Q1 2022. 33 funds tracked by Wall St. Rank hold TVGNW as of Q1 2026.

  • Linden Advisors held 649,999 shares of Tevogen Inc. Warrant worth $20.5K as of Q1 2026.
  • Linden Advisors left its Tevogen Inc. Warrant share count unchanged in Q1 2026.
  • Tevogen Inc. Warrant made up ﹤0.01% of Linden Advisors's portfolio in Q1 2026, its #538 holding.
  • Linden Advisors first reported a position in Tevogen Inc. Warrant in Q1 2022 and has held it in 17 quarters since.
  • Linden Advisors's Tevogen Inc. Warrant position peaked at $179K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held Tevogen Inc. Warrant as of Q1 2026.

Based on Linden Advisors's 13F filing for Q1 2026, filed 15 May 2026.